201405.16
0

Did Manufacturer of Low-T Drug Disclose Risks?

in Class Action

Five individuals have filed a lawsuit against the manufacturer of Low-T testosterone therapy drug AndroGel.  The suit has alleged that AbbVie and Abbott Laboratories  concealed facts about AndroGel and serious side-effects associated with the drug. According to the suit, the manufacturer failed to adequately research the risks of stroke or heart attack from testosterone therapy,…

201405.12
0

Actos Litigation Continues

in Class Action

Litigation involving the drug Actos (Pioglitazone) is continuing in the class actions posture following a verdict in a bellweather case in excess of $9 billion dollars. The manufacturer of Actos,Takeda Pharmaceutical Co., made more than $16 billion before Actos went generic in 2012.  While internal records show that Takeda knew about a link between Actos…